Phospholipase D1 Has a Pivotal Role in Interleukin-1β-Driven Chronic Autoimmune Arthritis through Regulation of NF-κB, Hypoxia-Inducible Factor 1α, and FoxO3a

REFERENCES

• Feldmann M. 2001. Pathogenesis of arthritis: recent research progression. Nat. Immunol. 2:771–773.
   PubMed Web of Science ®Google Scholar
• Firestein GS. 1996. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum. 39:1781–1790.
   PubMed Web of Science ®Google Scholar
• Mor A, Abramson SB, Pillinger MH. 2005. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin. Immunol. 115:118–128.
   PubMed Web of Science ®Google Scholar
• Min DS, Kwon TK, Park WS, Chang JS, Park SK, Ahn BH, Ryoo ZY, Lee YH, Lee YS, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, Jo YH. 2001. Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 22:1641–1647.
   PubMed Web of Science ®Google Scholar
• van den Berg WB, Miossec P. 2009. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat. Rev. Rheumatol. 5:549–553.
   PubMed Web of Science ®Google Scholar
• Burger D, Dayer JM, Palmer G, Gabay C. 2006. Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract. Res. Clin. Rheumatol. 20:879–896.
   PubMed Web of Science ®Google Scholar
• Brennan FM, McInnes IB. 2008. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118:3537–3545.
   PubMed Web of Science ®Google Scholar
• Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27–31.
   PubMed Web of Science ®Google Scholar
• Steed PM, Chow AH. 2001. Intracellular signaling by phospholipase D as a therapeutic target. Curr. Pharm. Biotechnol. 2:241–256.
   PubMedGoogle Scholar
• Su W, Chen Q, Frohman MA. 2009. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol. 5:1477–1486.
   PubMed Web of Science ®Google Scholar
• Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA. 2009. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat. Chem. Biol. 5:108–117.
   PubMed Web of Science ®Google Scholar
• Peng X, Frohman MA. 2012. Mammalian phospholipase D physiological and pathological roles. Acta Physiol. (Oxf.) 204(2):219–226.
   PubMed Web of Science ®Google Scholar
• Ahn M, Lee Y, Sim KB, Min DS, Matsumoto Y, Wie MB, Shin YG, Shin T. 2004. Increased expression of phospholipase D in the heart with experimental autoimmune myocarditis in Lewis rats. Immunol. Invest. 33:95–105.
   PubMed Web of Science ®Google Scholar
• Bluth M, Lin YY, Zhang H, Viterbo D, Zenilman M. 2008. Use of gene expression profiles in cells of peripheral blood to identify new molecular markers of acute pancreatitis. Arch. Surg. 143:227–233.
   PubMedGoogle Scholar
• Kim HR, Cho ML, Kim KW, Ju JH, Park MK, Oh HJ, Kim JS, Park SH, Lee SH, Kim HY. 2007. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways. Rheumatology (Oxford) 46:57–64.
   PubMed Web of Science ®Google Scholar
• Kim EK, Tucker DF, Yun SJ, Do KH, Kim MS, Kim JH, Kim CD, Birnbaum MJ, Bae SS. 2008. Linker region of Akt1/protein kinase B-alpha mediates platelet-derived growth factor-induced translocation and cell migration. Cell. Signal. 20:2030–2037.
   PubMedGoogle Scholar
• Kang DW, Park MH, Lee YJ, Kim HS, Kwon TK, Park WS, Min DS. 2008. Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFκB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells. J. Biol. Chem. 283:4094–4104.
   PubMedGoogle Scholar
• Kang DW, Park MH, Lee YJ, Kim HS, Lindsley CW, Brown HA, Min DS. 2011. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. Int. J. Cancer 128:805–816.
   PubMedGoogle Scholar
• Breitwieser W, Lyons S, Flenniken AM, Ashton G, Bruder G, Willington M, Lacaud G, Kouskoff V, Jones N. 2007. Feedback regulation of p38 activity via ATF-2 is essential for survival of embryonic liver cells. Genes Dev. 21:2069–2082.
   PubMedGoogle Scholar
• Camps M, Rückle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Françon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C. 2005. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. 11:936–943.
   PubMed Web of Science ®Google Scholar
• Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Min DS. 2010. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis. Cancer Res. 70:4233–4242.
   PubMed Web of Science ®Google Scholar
• Ahn BH, Kim SY, Kim EH, Choi KS, Kwon TK, Lee YH, Chang JS, Kim MS, Jo YH, Min DS. 2003. Transmodulation between PLD and c-Src enhances cell proliferation. Mol. Cell. Biol. 23:3103–3115.
   PubMedGoogle Scholar
• Kim SY, Min DS, Choi JS, Choi YS, Park HJ, Sung KW, Kim JM, Lee MY. 2004. Differential expression of phospholipase D isozymes in the hippocampus following kainic acid-induced seizures. J. Neuropathol. Exp. Neurol. 63:812–820.
   PubMedGoogle Scholar
• Kang DW, Min DS. 2010. Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFκB signaling pathway and enhances invasion of breast cancer cells. Cancer Lett. 294:125–133.
   PubMed Web of Science ®Google Scholar
• Pickens SR, Volin MV, Mandelin AM, Kolls JK, Pope RM, Shahrara S. 2010. IL-17 Contributes to angiogenesis in rheumatoid arthritis. J. Immunol. 184:3233–3241.
   PubMed Web of Science ®Google Scholar
• Schiff MH. 2000. Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Ann. Rheum. Dis. 59(Suppl 1):103–108.
   PubMed Web of Science ®Google Scholar
• Chen DY, Hsieh TY, Chen YM, Hsieh CW, Lan JL, Lin FJ. 2009. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease. Gerontology 55:250–258.
   PubMed Web of Science ®Google Scholar
• Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443–446.
   PubMed Web of Science ®Google Scholar
• Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ. 2000. Activation of the kappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351–361.
   PubMed Web of Science ®Google Scholar
• Lin A, Karin M. 2003. NF-kappaB in cancer: a marked target. Semin. Cancer Biol. 13:107–114.
   PubMed Web of Science ®Google Scholar
• Firestein GS, Manning AM. 1999. Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 42:609–621.
   PubMed Web of Science ®Google Scholar
• Neumann E, Lefèvre S, Zimmermann B, Gay S, Müller-Ladner U. 2010. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol. Med. 16:458–468.
   PubMed Web of Science ®Google Scholar
• Asahara H, Asanuma M, Ogawa N, Nishibayashi S, Inoue H. 1995. High DNA-binding activity of transcription factor NF-kappaB in synovial membranes of patients with rheumatoid arthritis. Biochem. Mol. Biol. Int. 37:827–832.
   PubMedGoogle Scholar
• Larsen H, Akhavani MA, Raatz Y, Paleolog EM. 2007. Gene expression studies to investigate disease mechanisms in rheumatoid arthritis: does angiogenesis play a role? Curr. Rheumatol. Rev. 3:243–251.
   Google Scholar
• Szekanecz Z, Koch AE. 2009. Angiogenesis and its targeting in rheumatoid arthritis. Vascul. Pharmacol. 51:1–7.
   PubMed Web of Science ®Google Scholar
• Huang H, Tindall DJ. 2007. Dynamic FoxO transcription factors. J. Cell Sci. 120(Pt 15):2479–2487.
   PubMed Web of Science ®Google Scholar
• Turrel-Davin F, Tournadre A, Pachot A, Arnaud B, Cazalis MA, Mougin B, Miossec P. 2010. FoxO3a involved in neutrophil and T cell survival is overexpressed in rheumatoid blood and synovial tissue. Ann. Rheum. Dis. 69:755–760.
   PubMedGoogle Scholar
• Helmchen B, Weckauf H, Ehemann V, Wittmann I, Meyer-Scholten C, Berger I. 2005. Expression pattern of cell cycle-related gene products in synovial stroma and synovial lining in active and quiescent stages of rheumatoid arthritis. Histol. Histopathol. 20:365–372.
   PubMedGoogle Scholar
• Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y. 2000. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 191:313–320.
   PubMed Web of Science ®Google Scholar
• Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. 2003. Anti-TNF-alpha therapies: the next generation. Nat. Rev. Drug Discov. 2:736–746.
   PubMed Web of Science ®Google Scholar
• Murray PJ. 2007. The JAK-STAT signaling pathway: input and output integration. J. Immunol. 178:2623–2629.
   PubMed Web of Science ®Google Scholar
• Im SH, Rao A. 2004. Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. Mol. Cells 18:1–9.
   PubMed Web of Science ®Google Scholar